Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series
Isaac Goncalves, Kate Burbury, Michael Michael, Amir Iravani, Aravind S. Ravi Kumar, Tim Akhurst, Ing S. Tiong, Piers Blombery, Michael S. Hofman, David Westerman, Rodney J. Hicks, Grace Kong
Dive into the research topics of 'Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series'. Together they form a unique fingerprint.